JPRN-UMIN000020389已完成未知
Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHD - Clinical trial of efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHD
Kanazawa University Hospital, Department of dermatology0 个研究点目标入组 5 人开始时间: 2016年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with a history of shock or hypersensitivity to this drug. 2.Patients who are complicated by infectious diseases. 3.Patients with a history of myocardial infarction or unstable angina. 4.Patients with reduced severe bone marrow function. 5.Women who may be pregnant or pregnant. 6.Lactating women
研究者
相似试验
已完成
2 期
Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19COVID-19 disease.COVID-19, virus not identifiedU07.2IRCT20081027001411N4Tehran University of Medical Sciences40
已完成
不适用
Efficacy and safety of tocilizumab monotherapy in patients with microscopic polyangiitisMicroscopic polyangiitisJPRN-UMIN000011242Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology10
已完成
不适用
Efficacy and safety of tocilizumab mono-therapy in patients with large vessel vasculitis (LVV; giant cell arteritis or Takayasu arteritis) and polymyalgia rheumatica (PMR)Rheumatoid arthritisJPRN-UMIN000008812Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity40
已完成
不适用
Efficacy and safety of tocilizumab mono-therapy in patients with adult-onset Still's diseaseRheumatoid arthritisJPRN-UMIN000007019Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity40
招募中
2 期
Evaluation the Efficacy and Safety of Tocilizumab in COVID-19COVID-19 pneumonia.Confirmed diagnosis of COVID-19RA01.0IRCT20151227025726N13Shahid Beheshti University of Medical Sciences40